Core Framework & Diagram Inflammatory Bowel Disease

Completely different. IBS is a functional gut disorder with no detectable inflammation or structural changes, primarily related to gut neurological sensitivity and the gut-brain axis. IBD has definite gut inflammation and structural damage, confirmable by endoscopy and tissue biopsy. Symptoms overlap but the nature, treatment, and long-term prognosis are completely different. If abdominal symptoms persist over six weeks — especially with bloody stool, unexplained weight loss, or nighttime symptoms — consider IBD possibility rather than treating as IBS directly.

Yes, especially long-term extensive ulcerative colitis (over eight to ten years with pan-colitis involvement). Crohn's disease has similar but slightly lower risk. This is why IBD patients need periodic colonoscopy monitoring — typically starting eight to ten years after diagnosis, every one to three years depending on extent of involvement. Effectively controlling inflammation is the most important means of reducing this risk.

IBD patients in remission have quality of life not significantly different from healthy people; most can work, exercise, and have children normally. The main challenges are: disease unpredictability, side effect management, and insufficient societal understanding. Effective disease management and psychological support are key to maintaining quality of life.

Evidence is limited and varies by strain and disease type. Some probiotics (like VSL#3, Lactobacillus rhamnosus GG) have some evidence for maintaining UC remission, but there's insufficient evidence to recommend them in Crohn's disease. Probiotics can be used as adjuncts but can't replace primary treatment medications. If using immunosuppressive drugs, consult a doctor before choosing probiotics.

Yes, and pregnancy outcomes in remission are close to the general population. The key: pregnancy risk during active disease is significantly elevated (preterm birth, low birth weight, etc.); some IBD medications are unsafe during pregnancy (like methotrexate, requiring stopping three to six months before trying to conceive); some drugs are safe during pregnancy (like mesalamine, most biologics during the first two trimesters). Plan a individualized approach with gastroenterology and obstetric physicians before conception.